Intellia Therapeutics Inc (NASDAQ:NTLA)

64.04
Delayed Data
As of Mar 01
 +3.57 / +5.90%
Today’s Change
9.18
Today|||52-Week Range
92.00
+17.72%
Year-to-Date

Today’s Trading

Previous close60.46
Today’s open61.50
Day’s range61.39 - 67.94
Volume1,566,506
Average volume (3 months)1,508,059
Market cap$3.6B
Data as of 4:17pm ET, 03/01/2021

Growth & Valuation

Earnings growth (last year)-13.81%
Earnings growth (this year)-20.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+34.55%
P/E ratioNM
Price/Sales52.52
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NKNantKwest Inc+0.79+2.43%
ARVNArvinas Inc-1.00-1.28%
RCKTRocket Pharmaceutica...+0.16+0.29%
MORMorphoSys AG+0.51+2.05%
Data as of 3:59pm ET, 03/01/2021

Financials

Next reporting dateMay 4, 2021
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$58.0M
Annual profit (last year)-$134.2M
Net profit margin-231.46%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts